DUBLIN--(BUSINESS WIRE)--The "Arachidonic Acid Market Size, Share & Trends Analysis Report by Form (Solid, Solvent), by Source (Plant, Animal), by Application (Infant Formula, Supplement), by Region (EU, APAC), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
The global arachidonic acid market is expected to reach USD 309.0 million by 2030, registering a CAGR of 4.3%
The growth is majorly driven by the rising demand for applications including infant formula and supplements. The growing need for essential minerals in baby food is likely to create demand for ARA-based infant formula across the globe over the forecast period.
The growing consumer awareness related to the benefits of ARA has led to the initiation of various marketing activities by different companies across regions. There is a rise in the cases of ARA deficiency, which has led to an increase in the intake of the same in different forms, such as injections, syrups, and tablets.
Growing awareness levels about the importance of preserving nutritive value are also anticipated to contribute to the industry's growth.
North America, led by the U.S., Mexico, and Canada, accounted for the largest share of the global revenue. The presence of prominent producers, such as A&Z Food Additives Co. Ltd, Cargill, and Cayman Chemical Company, developed sports & infant nutrition industry, and high consumer disposable income levels are expected to drive the region's growth.
Product manufacturers are focusing on in-house production, which is intended to improve product quality, having a direct relationship with the brand value of a company. Acquisitions and joint ventures are an integral part of this industry and enable companies to strengthen their position and hold across the industry.
Heavy investments by manufacturers in the development of low-cost production methods are anticipated to boost industry growth.
Arachidonic Acid Market Report Highlights
- The solid form segment is estimated to register the fastest CAGR from 2022 to 2030 on the account of the growing popularity of these products as a result of the increasing spending power of consumers on infant care and sports activities
- The animal source is expected to be the fastest-growing segment over the forecast period owing to the easy availability of several animal-based options, such as eggs, meat, poultry, and seafood
- The infant formula application segment is projected to register the fastest CAGR from 2022 to 2030 owing to the increasing awareness regarding the benefits of ARA in baby nutrition
- Central & South America is projected to be the fastest-growing region from 2022 to 2030 due to the increasing consumer spending on infant health and sports nutrition products
- Technology upgrades coupled with innovative product development are projected to drive the industry over the forecast period. The introduction of technologies, such as particle size reduction and microencapsulation techniques, are expected to boost the industry growth in the coming years
Company Profiles
- Cargill, Incorporated.
- Cabio Biotech (Wuhan) Co. Ltd.
- Cayman Chemical
- Guangdong Runke Bioengineering Co. Ltd.
- Koninklijke Dsm N.V.
- Avanti Polar Lipids, Inc.
- Bio-Techne Corporation
- Merck Kgaa
- A&Z Food Additives Co. Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/n2fm8s
